U.S. Markets close in 3 hrs 30 mins

Can Amedisys (AMED) Run Higher on Strong Earnings Estimate Revisions?

Zacks Equity Research

Amedisys Inc. (AMED), a leading provider of home health and hospice care services, is a company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AMED’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Amedisys could be a solid choice for investors.

Current Quarter Estimates for AMED

In the past 30 days, 4 estimates have gone higher for Amedisys with no downward revision in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 2 cents per share 30 days ago, to earnings of 1 penny a share today, a significant move.

Current Year Estimates for AMED

Meanwhile, Amedisys’s current year figures have seen 6 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, increasing from a loss of 5 cents per share 30 days ago to earnings of 6 cents per share today, a significant increase.

Bottom Line    

The stock has also started to move higher lately, adding 7.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

AMEDISYS INC (AMED): Free Stock Analysis Report

Zacks Investment Research